Abstract
Dry eye disease or keratoconjunctivitis sicca (KCS) is a common ocular surface disease that causes chronic ocular irritation and dry or gritty sensations of the ocular surface. Traditionally, KCS has been described as a secretion disorder of the lacrimal glands that leads to a deficiency in tear production. However, a growing body of evidence suggests KCS has a complex multifactorial etiology, which comprises tear dysfunction and a localized immune-mediated inflammatory response affecting the entire ocular surface (Stern et al., 1998). The inflammatory response observed in KCS patients with and without Sjögren’ s syndrome (SS) encompasses cellular and immunopathological abnormalities of the conjunctival epithelium including upregulation of inflammatory cytokines and molecular markers of the inflammatory pathway (Baudouin et al., 1992;Jones et al., 1994; Pflugfelder et al 1990;1999;Tsubota et al., 1999a;Smith et al., 2000). Mircheff and colleagues (1994) proposed that in KCS patients without SS, this inflammatory process results from altered membrane “trafficking” of the lacrimal acinar cells. These authors suggested that these changes arise due to expression of major histocompatibility (1999). Furthermore, epithelial cells produce TNF-a (Jones et al., 1998). Consequently, it can be postulated that this combination of increased HLA DR antigen expression and elevated levels of inflammatory cytokines within the conjunctival epithelium may represent the focus for cytotoxic reactions between epithelial cells and infiltrating lymphocytes, which would also help to perpetuate the local immune response.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
C. Baudouin, N. Haouat, F. Brignole, J. Bayle, and P. Gastaud, Immunological findings in conjunctival cells using immunofluorescence staining of impression cytology specimens.Br J Ophthalmol.76:545 (1992).
C. Baudouin, F. Brignole, F. Becquet, P.J. Pisella, and A. Goguel. Flow cytometry in impression cytology specimens: a new method for evaluation of conjunctival inflammation.Invest Ophthalmol Vis Sci.8:1458 (1997).
K.B. Bjerrum. Keratoconjunctivitis sicca and primary Sjpgren’s syndrome in a Danish population aged 30–60 years.Acta Ophthalmol Scand.75:281 (1997).
F. Brignole, M. De Saint Jean, M. Goldschild, F. Becquet, A. Goguel, and C. Baudouin. Expression of Fas-Fas ligand antigens and apoptotic marker APO2.7 by the human conjunctival epithelium: positive correlation with class II HLA DR expression in inflammatory ocular surface disorders.Exp Eye Res.67:687 (1998).
F. Brignole, P.J. Pisella, M. Goldschild, M. De Saint Jean, A. Goguel, and C. Baudouin, C. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes.Invest Ophthalmol Vis Sci.41:1356 (2000).
F. Brignole, P.J. Pisella, M. De Saint Jean, M. Goldschild, A. Goguel, and C. Baudouin. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A.Invest Ophthalmol Vis Sci.42:90 (2001).
M. De Saint Jean, F. Brignole, G. Feldman, A. Goguel, and C. Baudouin. Interferon gamma induces apoptosis and expression of inflammation-related proteins in Chang conjunctival cells.Invest Ophthalmol Vis Sci.40:2199 (1999).
N. Haneji, T. Nakamura, K. Takio, K. Yanagi, H. Higashiyama, I. Saito, S. Noji, H. Sugino, and Y. Hayashi. Identification of a-fodrin as a candidate autoantigen in primary Sjogren’s syndrome.Science.276:604 (1997).
T. Hikichi, A. Yoshida, Y. Fukui, T. Hamano, M. Ri, K. Araki, K. Horimoto, E. Takamura, K. Kitagawa, M. Oyama, et al. Prevalence of dry eye in Japanese eye centers.Graefe Arch Clin Exp Ophthalmol.233:555 (1995).
M. Iwata, A. Kiritoshi, M.I. Roat, A. Yagihashi, and R.A. Thoft. Regulation of HLA class II antigen expression on cultured comeal epithelium by interferon gamma.Invest Ophthalmol Vis Sci.33:2714 (1992).
D.T. Jones, D. Monroy, Z. Ji, S.S. Atherton, and S.C. Pflugfelder. Sjogren’s syndrome: cytokine and Epstein- Barr viral gene expression within the conjunctival epithelium.Invest Ophthlmol Vis Sci.35:3493 (1994).
D.T. Jones, D. Monroy, Z. Ji, and S.C. Pflugfelder. Alterations of ocular surface gene expression in Sjogren’s syndrome. AdvExp Med Biol.438:533 (1998).
K.S. Kunert, A.S. Tisdale, M.E. Stern, J.A. Smith, and I.K. Gipson. Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes.Arch Ophthalmol.118:1489 (2000).
A.K. Mircheff, J.P. Gierow, and R.L. Wood. Traffic of major histocompatibility complex class II molecules in rabbit lacrimal gland acinar cells.Invest Ophthalmol Vis Sci.35:3943 (1994).
S.C. Pflugfelder, A.J. Huang, W. Feuer, P.T. Chuchovski, I.C. Pereira, and S.C. Tseng. Conjunctival cytologic features of primary Sj0gren’s syndrome.Ophthalmology.97:985 (1990).
S.C. Pflugfelder, D. Jones, Z. Ji, A. Afonso, and D. Monroy. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren’s syndrome keratoconjunctivitis sicca.Curr Eye Res.19:201 (1999).
P.J.M. Philip, C. Sartiaux, and the GEIL. Standardized multicentric quantimetry of differentiation antigens expression. The GEIL’s approach in acute lymphoblastic leukemia.Leukemia Lymphoma.13:45 (1994).
P.J. Pisella, F. Brignole, C. Debbasch, P.A. Lozato, C. Creuzot-Garcher, J. Bara, P. Saiag, J.M. Warnet, and C. Baudouin. Flow cytometric analysis of conjunctival epithelium in ocular rosacea and keratoconjunctivitis sicca.Ophthalmology.107:1841 (2000).
K. Sall, O.D. Stevenson, T.K. Mundorf, B.L. Reis, and the CsA Phase 3 Study Group. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease.Ophthalmology.107:631 (2000).
O.D. Schein, B. Munoz, J.M. Tielsch, K. Bandeen-Roche, S. West. Prevalence of dry eye among the elderly. AmJ Ophthalmol.124:723 (1997).
J.A. Smith, M.E. Stern, J. Gao, T.A. Schwalb, D.C. Rupp, and S.M. Whitcup. Conjunctival inflammation in non-Sj0gren’s syndrome and Sj0gren’s syndrome keratoconjunctivitis sicca.Invest Ophthalmol Vis Sci.41:S276 (2000).
M.E. Stern, R.W. Beurman, R.I. Fox, J. Gao, A.K. Mircheff, and S.C. Pflugfelder. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands.Cornea.17:584 (1998).
D. Stevenson, J. Tauber, and B.L. Reiss, B. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group.Ophthalmology.107:967 (2000).
J. Tauber. A dose-ranging clinical trial to assess the safety and efficacy of cyclosporine ophthalmic emulsion in patients with keratoconjunctivitis sicca.Adv Exp Med Biol.438:969 (1998).
K. Tsubota, T. Fujihara, K. Saito, and T. Takeuchi. Conjunctival epithelium expression of HLA-DR in dry eye patients.Ophthalmologica.213:16 (1999a).
K. Tsubota, K. Fukagawa, T. Fujihara, S. Shimmura, I. Saito, K. Saito, and T. Takeuchi. Regulation of human leukocyte antigen expression in human conjunctival epithelium.Invest Ophthalmol Vis Sci.40:28 (1999b).
K. Turner, S.C. Pflugfelder, Z. Ji, W.J. Feuer, M.E. Stern, and B.L. Reis. Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic solution.Cornea.19: 492 (2000).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic/Plenum Publishers
About this chapter
Cite this chapter
Baudouin, C., Brignole, F., Pisella, PJ., De Saint Jean, M., Goguel, A. (2002). Flow Cytometric Analysis of the Inflammatory Marker HLA DR in Dry Eye Syndrome: Results from 12 Months of Randomized Treatment with Topical Cyclosporin A. In: Sullivan, D.A., Stern, M.E., Tsubota, K., Dartt, D.A., Sullivan, R.M., Bromberg, B.B. (eds) Lacrimal Gland, Tear Film, and Dry Eye Syndromes 3. Advances in Experimental Medicine and Biology, vol 506. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0717-8_107
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0717-8_107
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5208-2
Online ISBN: 978-1-4615-0717-8
eBook Packages: Springer Book Archive